Long noncoding RNA in hematopoiesis and immunity

Ansuman T Satpathy; Howard Y Chang

doi:10.1016/j.immuni.2015.05.004

Long noncoding RNA in hematopoiesis and immunity

Immunity. 2015 May 19;42(5):792-804. doi: 10.1016/j.immuni.2015.05.004.

Authors

Ansuman T Satpathy¹, Howard Y Chang²

Affiliations

¹ Howard Hughes Medical Institute and Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
² Howard Hughes Medical Institute and Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: howchang@stanford.edu.

PMID: 25992856
DOI: 10.1016/j.immuni.2015.05.004

Abstract

Dynamic gene expression during cellular differentiation is tightly coordinated by transcriptional and post-transcriptional mechanisms. An emerging theme is the central role of long noncoding RNAs (lncRNAs) in the regulation of this specificity. Recent advances demonstrate that lncRNAs are expressed in a lineage-specific manner and control the development of several cell types in the hematopoietic system. Moreover, specific lncRNAs are induced to modulate innate and adaptive immune responses. lncRNAs can function via RNA-DNA, RNA-RNA, and RNA-protein target interactions. As a result, they affect several stages of gene regulation, including chromatin modification, mRNA biogenesis, and protein signaling. We discuss recent advances, future prospects, and challenges in understanding the roles of lncRNAs in immunity and immune-mediated diseases.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Gene Expression Regulation / immunology*
Hematopoiesis / immunology*
Humans
Immunity*
RNA, Long Noncoding / immunology*

Substances

RNA, Long Noncoding

Grants and funding

Howard Hughes Medical Institute/United States